Impact of screening programme to prevent anal cancer in high-risk patients with HIV - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue HIV Medicine Année : 2023

Impact of screening programme to prevent anal cancer in high-risk patients with HIV

Résumé

INTRODUCTION: We assessed the impact of a nationwide screening programme to reduce the risk of anal cancer in a large cohort of high-risk patients with HIV. METHODS: From a large database from one referral centre, all high-risk patients with HIV (men who have sex with men, history of anal or genital warts, or previous cervix human papillomavirus-related lesions) who were eligible to enter the French anal cancer screening programme (2011-2020) were retrospectively included. Adherence to the screening programme was defined as no interval >18 months between two visits. Standardized management included perianal visualization and standard anoscopy with biopsies of macroscopic abnormalities. RESULTS: Overall, 700 patients with HIV were included (median follow-up 8.4 years [interquartile range 4.3-9.2] and 1491.6 patient-years), and 336 had one or more proctology visit. A total of 13 patients were diagnosed with anal squamous cell carcinomas. The risk of anal cancer was higher with anal intra-epithelial neoplasia grade 3 (AIN3; hazard ratio [HR] 44.5 [95% confidence interval {CI} 11.2-176.6], p < 0.001), AIN2 (HR 11.9 [95% CI 2.1-66.9], p = 0.005), or high-grade dysplasia (HR 23.4 [95% CI 7.9-69.1], p < 0.001) than with low-grade dysplasia or no lesion. Among the patients who were strictly adherent to the screening programme (4.6% [32/700]), we did not report any AIN or anal cancer, but we also did not observe any significant reduction in the risk of anal cancer (p = 0.51), AIN3 (p = 0.28), high-grade dysplasia (p = 0.19), or any AIN lesions (p = 0.10) compared with non-adherent patients. In contrast, screened patients were more likely to be diagnosed with anal warts (HR 3.71 [95% CI 2.14-6.42], p < 0.001). CONCLUSION: Macroscopic high-grade dysplasia lesions are associated with a higher risk of developing anal cancer. Despite finding no cases of cancer during the screening programme, we also did not demonstrate a clear benefit from our screening programme for the prevention of anal cancer in high-risk patients with HIV.
Fichier sous embargo
Fichier sous embargo
Fichier sous embargo
0 0 19
Année Mois Jours
Avant la publication
jeudi 30 mai 2024
Fichier sous embargo
0 0 19
Année Mois Jours
Avant la publication
jeudi 30 mai 2024
Fichier sous embargo
jeudi 30 mai 2024
Connectez-vous pour demander l'accès au fichier

Dates et versions

hal-04338137 , version 1 (22-02-2024)

Identifiants

Citer

Eloïse Leclerc, Christine Jacomet, Laurent Siproudhis, Laurent Abramowitz, Bruno Pereira, et al.. Impact of screening programme to prevent anal cancer in high-risk patients with HIV. HIV Medicine, 2023, Hiv Medicine, ⟨10.1111/hiv.13594⟩. ⟨hal-04338137⟩
36 Consultations
1 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More